Hybrid additive and subtractive machine tools – Research and industrial developments von Flynn, Joseph M., Shokrani, Alborz, Newman, Stephen T., Dhokia, Vimal

Volltext

Entering the era of targeted therapy for chronic lymphocytic leukemia: impact on the practicing clinician von Byrd, John C, Jones, Jeffrey J, Woyach, Jennifer A, Johnson, Amy J, Flynn, Joseph M

Volltext

Tetraspanin CD37 Directly Mediates Transduction of Survival and Apoptotic Signals von Lapalombella, Rosa, Yeh, Yuh-Ying, Wang, Liwen, Ramanunni, Asha, Rafiq, Sarwish, Jha, Shruti, Staubli, Justin, Lucas, David M., Mani, Rajeswaran, Herman, Sarah E.M., Johnson, Amy J., Lozanski, Arletta, Andritsos, Leslie, Jones, Jeffrey, Flynn, Joseph M., Lannutti, Brian, Thompson, Peter, Algate, Paul, Stromatt, Scott, Jarjoura, David, Mo, Xiaokui, Wang, Dasheng, Chen, Ching-Shih, Lozanski, Gerard, Heerema, Nyla A., Tridandapani, Susheela, Freitas, Michael A., Muthusamy, Natarajan, Byrd, John C.

Volltext

Randomized phase 2 study of obinutuzumab monotherapy in symptomatic, previously untreated chronic lymphocytic leukemia von Byrd, John C., Flynn, Joseph M., Kipps, Thomas J., Boxer, Michael, Kolibaba, Kathryn S., Carlile, David J., Fingerle-Rowson, Guenter, Tyson, Nicola, Hirata, Jamie, Sharman, Jeff P.

Volltext

A simple method to estimate flow restriction for dual ventilation of dissimilar patients: The BathRC model von Plummer, Andrew R, du Bois, Jonathan L, Flynn, Joseph M, Roesner, Jens, Lee, Siu Man, Magee, Patrick, Thornton, Malcolm, Padkin, Andrew, Gill, Harinderjit S

Volltext

Phase II Study of Flavopiridol in Relapsed Chronic Lymphocytic Leukemia Demonstrating High Response Rates in Genetically High-Risk Disease von Lin, Thomas S., Ruppert, Amy S., Johnson, Amy J., Fischer, Beth, Heerema, Nyla A., Andritsos, Leslie A., Blum, Kristie A., Flynn, Joseph M., Jones, Jeffrey A., Hu, Weihong, Moran, Mollie E., Mitchell, Sarah M., Smith, Lisa L., Wagner, Amy J., Raymond, Chelsey A., Schaaf, Larry J., Phelps, Mitch A., Villalona-Calero, Miguel A., Grever, Michael R., Byrd, John C.

Volltext

Lymphocyte cytosolic protein 1 is a chronic lymphocytic leukemia membrane-associated antigen critical to niche homing von Dubovsky, Jason A., Chappell, Danielle L., Harrington, Bonnie K., Agrawal, Kitty, Andritsos, Leslie A., Flynn, Joseph M., Jones, Jeffrey A., Paulaitis, Michael E., Bolon, Brad, Johnson, Amy J., Byrd, John C., Muthusamy, Natarajan

Volltext

Effect of Porosity and Injection Ratio on the Performance of Transpiration Cooling through Gyroids von Brimacombe, Benjamin J., Scobie, James A., Flynn, Joseph M., Sangan, Carl M., Pountney, Oliver J.

Volltext

Ibrutinib treatment improves T cell number and function in CLL patients von Long, Meixiao, Beckwith, Kyle, Do, Priscilla, Mundy, Bethany L, Gordon, Amber, Lehman, Amy M, Maddocks, Kami J, Cheney, Carolyn, Jones, Jeffrey A, Flynn, Joseph M, Andritsos, Leslie A, Awan, Farrukh, Fraietta, Joseph A, June, Carl H, Maus, Marcela V, Woyach, Jennifer A, Caligiuri, Michael A, Johnson, Amy J, Muthusamy, Natarajan, Byrd, John C

Volltext

Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytes von Dubovsky, Jason A., Beckwith, Kyle A., Natarajan, Gayathri, Woyach, Jennifer A., Jaglowski, Samantha, Zhong, Yiming, Hessler, Joshua D., Liu, Ta-Ming, Chang, Betty Y., Larkin, Karilyn M., Stefanovski, Matthew R., Chappell, Danielle L., Frissora, Frank W., Smith, Lisa L., Smucker, Kelly A., Flynn, Joseph M., Jones, Jeffrey A., Andritsos, Leslie A., Maddocks, Kami, Lehman, Amy M., Furman, Richard, Sharman, Jeff, Mishra, Anjali, Caligiuri, Michael A., Satoskar, Abhay R., Buggy, Joseph J., Muthusamy, Natarajan, Johnson, Amy J., Byrd, John C.

Volltext

BTKC481S-Mediated Resistance to Ibrutinib in Chronic Lymphocytic Leukemia von Woyach, Jennifer A, Ruppert, Amy S, Guinn, Daphne, Lehman, Amy, Blachly, James S, Lozanski, Arletta, Heerema, Nyla A, Zhao, Weiqiang, Coleman, Joshua, Jones, Daniel, Abruzzo, Lynne, Gordon, Amber, Mantel, Rose, Smith, Lisa L, McWhorter, Samantha, Davis, Melanie, Doong, Tzyy-Jye, Ny, Fan, Lucas, Margaret, Chase, Weihong, Jones, Jeffrey A, Flynn, Joseph M, Maddocks, Kami, Rogers, Kerry, Jaglowski, Samantha, Andritsos, Leslie A, Awan, Farrukh T, Blum, Kristie A, Grever, Michael R, Lozanski, Gerard, Johnson, Amy J, Byrd, John C

Volltext

Horner Syndrome Due to Carotid Dissection von Flaherty, Patrick M., DO, Flynn, Joseph M., DO

Volltext

Phosphatidylinositol 3-kinase-δ inhibitor CAL-101 shows promising preclinical activity in chronic lymphocytic leukemia by antagonizing intrinsic and extrinsic cellular survival sig... von Herman, Sarah E.M., Gordon, Amber L., Wagner, Amy J., Heerema, Nyla A., Zhao, Weiqiang, Flynn, Joseph M., Jones, Jeffrey, Andritsos, Leslie, Puri, Kamal D., Lannutti, Brian J., Giese, Neill A., Zhang, Xiaoli, Wei, Lai, Byrd, John C., Johnson, Amy J.

Volltext

A generative multi-agent design methodology for additively manufactured parts inspired by termite nest building von Dhokia, Vimal, Essink, Wesley P., Flynn, Joseph M.

Volltext

The regulation of tumor‐suppressive microRNA, miR‐126, in chronic lymphocytic leukemia von Guinn, Daphne, Lehman, Amy, Fabian, Catherine, Yu, Lianbo, Maddocks, Kami, Andritsos, Leslie A., Jones, Jeffrey A., Flynn, Joseph M., Jaglowski, Samantha M., Woyach, Jennifer A., Byrd, John C., Johnson, Amy J.

Volltext

A single‐institution retrospective cohort study of first‐line R‐EPOCH chemoimmunotherapy for Richter syndrome demonstrating complex chronic lymphocytic leukaemia karyotype as an ad... von Rogers, Kerry A., Huang, Ying, Ruppert, Amy S., Salem, Galena, Stephens, Deborah M., Heerema, Nyla A., Andritsos, Leslie A., Awan, Farrukh T., Byrd, John C., Flynn, Joseph M., Maddocks, Kami J., Jones, Jeffrey A.

Volltext

Safety and activity of BTK inhibitor ibrutinib combined with ofatumumab in chronic lymphocytic leukemia: a phase 1b/2 study von Jaglowski, Samantha M., Jones, Jeffrey A., Nagar, Veena, Flynn, Joseph M., Andritsos, Leslie A., Maddocks, Kami J., Woyach, Jennifer A., Blum, Kristie A., Grever, Michael R., Smucker, Kelly, Ruppert, Amy S., Heerema, Nyla A., Lozanski, Gerard, Stefanos, Mona, Munneke, Brian, West, Jamie-Sue, Neuenburg, Jutta K., James, Danelle F., Hall, Nathan, Johnson, Amy J., Byrd, John C.

Volltext

Flavopiridol treatment of patients aged 70 or older with refractory or relapsed chronic lymphocytic leukemia is a feasible and active therapeutic approach von STEPHENS, Deborah M, RUPPERT, Amy S, BLUM, Kristie, JONES, Jeffrey, FLYNN, Joseph M, JOHNSON, Amy J, JIA JI, PHELPS, Mitch A, GREVER, Michael R, BYRD, John C

Volltext

A new methodology for identifying location errors in 5-axis machine tools using a single ballbar set-up von Flynn, Joseph M, Shokrani, Alborz, Vichare, Parag, Dhokia, Vimal, Newman, Stephen T

Volltext

ER stress and autophagy: new discoveries in the mechanism of action and drug resistance of the cyclin-dependent kinase inhibitor flavopiridol von Mahoney, Emilia, Lucas, David M., Gupta, Sneha V., Wagner, Amy J., Herman, Sarah E.M., Smith, Lisa L., Yeh, Yuh-Ying, Andritsos, Leslie, Jones, Jeffrey A., Flynn, Joseph M., Blum, Kristie A., Zhang, Xiaoli, Lehman, Amy, Kong, Hui, Gurcan, Metin, Grever, Michael R., Johnson, Amy J., Byrd, John C.

Volltext